ES474611A1 - Purifying Polyribosyl Ribitol Phosphate (PRP) and Vaccines containing Immunologically Active PRP - Google Patents

Purifying Polyribosyl Ribitol Phosphate (PRP) and Vaccines containing Immunologically Active PRP

Info

Publication number
ES474611A1
ES474611A1 ES474611A ES474611A ES474611A1 ES 474611 A1 ES474611 A1 ES 474611A1 ES 474611 A ES474611 A ES 474611A ES 474611 A ES474611 A ES 474611A ES 474611 A1 ES474611 A1 ES 474611A1
Authority
ES
Spain
Prior art keywords
prp
immunologically active
vaccines containing
antibody
purifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES474611A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/846,466 external-priority patent/US4196192A/en
Priority claimed from US05/846,488 external-priority patent/US4220717A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES474611A1 publication Critical patent/ES474611A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides methods for the purification of polyribosyl ribitol phosphate (PRP) from Haemophilus influenzae type b cultures, as well as novel forms of immunologically active PRP obtainable by such methods and combined vaccines containing immunologically active PRP and Bordetella pertussis antigens. The purification methods involve removing contaminants to a low level by treating the PRP in the form of a hexadecyltrimethyl ammonium bromide complex with a calcium phosphate adsorbent (hydroxylapatite) in a phosphate buffer, and may be practiced either as a batch process or as a column process. The purified PRP thus obtainable is immunologically active and may be used with B. pertussis antigens to form a combined vaccine which elicits anti-PRP antibody and antipercussis antibody formations in young animals. This sera with anti-PRP antibody exhibits a strong bactericidal activity.
ES474611A 1977-10-28 1978-10-27 Purifying Polyribosyl Ribitol Phosphate (PRP) and Vaccines containing Immunologically Active PRP Expired ES474611A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/846,466 US4196192A (en) 1977-10-28 1977-10-28 Combined Haemophilus influenzae type b and pertussis vaccine
US05/846,488 US4220717A (en) 1977-12-22 1977-12-22 Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Publications (1)

Publication Number Publication Date
ES474611A1 true ES474611A1 (en) 1980-01-16

Family

ID=27126641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES474611A Expired ES474611A1 (en) 1977-10-28 1978-10-27 Purifying Polyribosyl Ribitol Phosphate (PRP) and Vaccines containing Immunologically Active PRP

Country Status (25)

Country Link
JP (1) JPS5480408A (en)
AR (1) AR218932A1 (en)
AU (1) AU520902B2 (en)
BE (1) BE871586A (en)
CA (1) CA1117866A (en)
CH (1) CH649781A5 (en)
DD (1) DD140701A5 (en)
DE (1) DE2845745A1 (en)
DK (1) DK154327C (en)
ES (1) ES474611A1 (en)
FI (1) FI63674C (en)
FR (1) FR2407000B1 (en)
GB (1) GB2007244B (en)
GR (1) GR73991B (en)
HU (1) HU178166B (en)
IE (1) IE47474B1 (en)
IL (1) IL55433A (en)
IT (1) IT1107570B (en)
NL (1) NL7810753A (en)
NO (1) NO149611C (en)
NZ (1) NZ188211A (en)
PH (1) PH15882A (en)
PL (1) PL210545A1 (en)
SE (1) SE430753B (en)
YU (1) YU250878A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE889979A (en) * 1981-08-14 1982-02-15 Smith Kline Rit PROCESS FOR THE PREPARATION OF PURIFIED ANTIGENIC CAPSULAR BACTERIAL POLYSACCHARIDES, PRODUCTS OBTAINED AND THEIR USE
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
US4744982A (en) * 1982-08-24 1988-05-17 Hunter Kenneth W Human monoclonal antibody reactive with polyribosylribitol phosphate
IL98715A0 (en) * 1990-08-13 1992-07-15 American Cyanamid Co Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
HU9400426D0 (en) * 1991-08-16 1994-05-30 Merck & Co Inc Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
IL24946A (en) * 1965-01-19 1969-05-28 Merck & Co Inc Process for preparing b. pertussis antigens
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
NL174267B (en) * 1969-05-20 Roussel Uclaf IMPROVEMENT OF THE PROCESS FOR THE PREPARATION OF A SOMATIC ANTIGEN ACCORDING TO DUTCH PATENT 169754 AND PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION.
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
FR2253499B1 (en) * 1973-12-10 1977-11-04 Fabre Sa Pierre
DE2461439C3 (en) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Process for the preparation of a protective antigen from Bordetella pertussis and agent containing the same
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Also Published As

Publication number Publication date
FR2407000B1 (en) 1983-01-21
PH15882A (en) 1983-04-13
IE782146L (en) 1979-04-28
AU520902B2 (en) 1982-03-04
FI63674B (en) 1983-04-29
PL210545A1 (en) 1980-02-25
FR2407000A1 (en) 1979-05-25
FI783269A (en) 1979-04-29
BE871586A (en) 1979-04-27
DK154327B (en) 1988-11-07
NL7810753A (en) 1979-05-02
AU4108178A (en) 1980-05-01
IL55433A (en) 1982-09-30
NZ188211A (en) 1984-09-28
IT7851621A0 (en) 1978-10-24
AR218932A1 (en) 1980-07-15
DE2845745A1 (en) 1979-05-10
JPS6231694B2 (en) 1987-07-09
CA1117866A (en) 1982-02-09
NO149611B (en) 1984-02-13
IT1107570B (en) 1985-11-25
SE7811192L (en) 1979-04-29
NO783635L (en) 1979-05-02
GB2007244B (en) 1982-03-31
JPS5480408A (en) 1979-06-27
GR73991B (en) 1984-06-06
DK154327C (en) 1989-04-03
DK479578A (en) 1979-04-29
SE430753B (en) 1983-12-12
CH649781A5 (en) 1985-06-14
DE2845745C2 (en) 1987-10-01
IE47474B1 (en) 1984-03-21
HU178166B (en) 1982-03-28
FI63674C (en) 1983-08-10
IL55433A0 (en) 1978-10-31
YU250878A (en) 1983-12-31
DD140701A5 (en) 1980-03-26
NO149611C (en) 1984-05-23
GB2007244A (en) 1979-05-16

Similar Documents

Publication Publication Date Title
ATE87003T1 (en) OLIGOSACCHARIDES, IMMUNOGENS AND VACCINES AND METHODS OF MANUFACTURE OF SUCH OLIGOSACCHARIDES, IMMUNOGENS AND VACCINES.
DK475779A (en) PROCEDURE FOR MANUFACTURING MEMBRANE PROTEINS FROM NEISSERIA MENINGITIDIS AND VACCINE CONTAINING SUCH MEMBRANE PROTEINS
SE8305535L (en) PHARMACEUTICAL PREPARATION WITH ANTINICOTIC EFFECTS AND PROCEDURES FOR PREPARING THEREOF
TR199801154T2 (en) Separation of the medium boiling agent from the boiling agent mixture.
DE3481514D1 (en) NEW FRUCTOSYLTSANSFERASE AND METHOD FOR PRODUCING FRUCTOSYL DISACCHARIDES, AND A NEW HALOSACCHAROSE.
ES487046A1 (en) Purified bacterial proteoglycans, process for their preparation and vaccine containing them.
NO934379L (en) Additive with trace elements, as well as methods of making them
ES474611A1 (en) Purifying Polyribosyl Ribitol Phosphate (PRP) and Vaccines containing Immunologically Active PRP
ATE119196T1 (en) METHOD FOR PRODUCING A FACTOR-VIIA ENRICHED FRACTION AND USE THEREOF AS A MEDICINAL PRODUCT.
US3957582A (en) Purification of urokinase
ATE87486T1 (en) PROCESS FOR PRODUCTION OF TOXOID.
DE3787887D1 (en) Process for growing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine.
GB1492596A (en) Tetanus toxoid and process for its manufacture
ATE107516T1 (en) PASTEURELLA VACCINE.
FR2597344B1 (en) IMPROVEMENT IN THE PROCESS OF PURIFYING PROTEIN ANTIGENS FROM BACTERIA BELONGING TO THE GENUS BORDETELLA, WITH A VIEW TO OBTAINING A CELLULAR VACCINE.
GR3018440T3 (en) Novel vaccine and method therefor.
ATE420951T1 (en) PROTECTIVE EPITOPES OF ADENYLATE CYCLASE-HEMOLYSIN (AC-HLY) AND THEIR USE FOR TREATING OR PREVENTING BORDETELLA INFECTIONS
DE69330496D1 (en) METHOD AND INTERMEDIATE PRODUCTS FOR THE ASYMMETRICAL SYNTHESIS OF CAMPTOTHECIN AND CAMPTOTHECIN ANALOGS
PT78043B (en) Process for the preparation of antisebhorreic sinalised compositions conaining a silicagel
DE3777743D1 (en) METHOD FOR PRODUCING 1,4-DIAZABICYCLO (2,2,2) -OCTANES.
DE3785266D1 (en) MASS PRODUCTION STRAP OF EPSILON-POLY-L-LYSINE, METHOD TO USE THIS STEM AND METHOD OF PRODUCING EPSILON-POLY-L-LYSINE.
ES401796A2 (en) Certain 2,4-diamino-5-benzyl-6-alkylthiopyrimidines
DE3364803D1 (en) Method of preparing an immunogen of pasteurella multocida
GB923544A (en) A new antibiotic-glumamycin
SU551894A2 (en) METHOD OF CLEANING VIRUS-CONTAINING SUSPENSION